Oropharyngeal cancer - Is it time to change management according to human papilloma virus status?

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 20, Issue 2, 2012, Pages

  Mehanna, Hisham ^a,b   Olaleye, Oladejo ^a,b   Licitra, Lisa ^c  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^b WARWICK HOSPITAL   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

human papilloma virus; oropharyngeal cancer; tongue base; tonsil

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; PANITUMUMAB; PROTEIN P16;

CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INCIDENCE; MORTALITY; MULTIMODALITY CANCER THERAPY; OROPHARYNX CANCER; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REAL TIME POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; ROBOTICS; SENSITIVITY AND SPECIFICITY; SMOKING; SWALLOWING; TREATMENT RESPONSE; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS 16; HUMANS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84859100651     PISSN: 10689508     EISSN: 15316998     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3283509735     Document Type: Review

References (52)

1. Licitra L, Zigon G, Gatta G, et al. Human papillomavirus in HNSCC: a European epidemiologic perspective. Hematol Oncol Clin North Am 2008; 22:1143-1153.
2. Chaturvedi AK, Engels EA, Anderson WF, Gillison MF. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26:612-619; doi.org/10.1200/JCO.2007.14.1713.
3. National Cancer Intelligence Network. Profile of head and neck cancers in England 2010. http://www.ncin.org.uk/cancer-type-and-topic-specific-work/ cancer-type-specific-work/head-neck.aspx. [Accessed 1 October 2011]
4. Näsman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009; 125:362-366. This is an interesting study showing progressive increase of HPV-positive oropharyngeal cancer in Stockholm since the 1970s.
5. Attner P, Du J, Näsman A, et al. Human papillomavirus and survival in patients with base of tongue cancer. Int J Cancer 2010; 128:2892-2897.
6. Mehanna H, Beech T, Nicholson T, et al. The prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer: a systematic review and meta-analysis of trends by time and region. Head Neck (in press). This study demonstrates the rise in HPV-positive oropharyngeal carcinoma worldwide.
7. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100:261-269. (Pubitemid 351480538)
8. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363:24-35. This is a landmark study, demonstrating the possibility of improving prognostication beyond HPV status alone, and the possible interaction between smoking and HPV.
9. Granata R, Miceli R, Orlandi E, et al. Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study. Ann Oncol 2011. [Epub ahead of print] This review validates the prognostic classifier above, and demonstrates that it is effective in a different (European) population.
10. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24:736-747. doi.org/10.1200/JCO. 2004.00.3335.
11. British Association of Otorhinolaryngologists-Head and Neck Surgeons (ENT-UK). Head and neck cancer: multidisciplinary management guidelines 2011. http://www.entuk.org/head-and-neck. [Accessed 1 December 2011]
12. Grégoire V, Lefebvre JL, Licitra L, Felip E, EHNS-ESMO-ESTRO Guidelines Working Group. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 (Suppl 5):v184-v186.
13. Worden FP, Kumar B, Lee JS, et al. Chemoselection as astrategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol 2008; 26: 3138-3146.
14. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006; 24:5630-5636. This study demonstrates the prognostic effect of HPV status in surgically treated patients. (Pubitemid 46631302)
15. Cohen M, Weinstein GS, O'Malley BW, et al. Transoral robotic surgery and human papillomavirus status: oncologic results. Head Neck 2010; 33:573-580. doi.org/10.1002/hed.21500. Results of HPV status in patients treated by robotic transoral surgery.
16. Mellin H, Friesland S, Lewensohn R, et al. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 2000; 89:300-304. (Pubitemid 30430748)
17. Lassen P, Eriksen JG, Krogdahl A, et al. The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA. Radiother Oncol 2011; 100:49-55.
18. Thavaraj S, Stokes A, Guerra E, et al. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice. J Clin Pathol 2011; 64:308-312. This is a good study demonstrating the use of a pragmatic protocol for HPV assessment in clinical practice.
19. Vermorken JB, Stöhlmacher J, Kelly Oliner K, et al. Safety and efficacy of pantumimab in HPV+ and HPV- recurrent/metastatic squamous cell carcinoma of head and neck cancer: analysis of the phase 3 SPECTRUM trial [abstract], ECCO; 2011. http://new.eccoorg.eu/ecco-content/ 2011StockholmLateBreakingflipbook/index.html#/17/zoomed. [Accessed 1 December 2011]
20. Harrington KJ, Berrier A, Robinson M, et al. Phase IIstudy of oral lapatinib, a dual-tyrosine kinase inhibitor, combinedwith chemoradiotherapy (CRT) in patients (pts) with locally advanced, unresected squamous cell carcinoma of the head and neck (SCCHN) [abstract]. J Clin Oncol 2010; 28:15s.
21. Adelstein DJ, Rodriguez CP. Human Papillomavirus: Changing Paradigms in Oropharyngeal Cancer. Curr Oncol Rep 2010; 12:115-120.
22. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363:24-35. [08]
23. Black CC, Bentley HA, Davis TH, Tsongalis GJ. Use of aLinear Array for the Detection of Human Papillomavirus Genotypes in Head and Neck Cancer. Arch Pathol Lab Med 2010; 134:1813-1817.
24. Blomberg M, Nielsen A, Munk C, Kjaer SK. Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites. Int J Cancer 2011; 129:733-741.
25. Bonifazi M, Malvezzi M, Bertuccio P, Edefonti V, et al. Age-period-cohort analysis of oral cancer mortality in Europe: The end of an epidemic? Eur J Cancer 2011; 47(5):400-407, 2011 May.
26. Cohen M, Weinstein GS, O'Malley BW, et al. Transoral robotic surgery and human papillomavirus status: oncologic results. Head Neck 2010; 33:573-580. doi.org/10.1002/hed.21500. [15]
27. Cohen MA, Weinstein GS, O'Malley BW, Feldman M, et al. Transoral robotic surgery and human papillomavirus status: oncologic results. Head and Neck 2011; 33:573-580.
28. Coughlin A, Resto VA. Oral Cavity Squamous Cell Carcinoma and the Clinically N0 Neck: The Past, Present, and Future of Sentinel Lymph Node Biopsy. Curr Oncol Rep 2010; 12:129-135.
29. Fasunla AJ, Greene BH, Timmesfeld N, Wiegand S, et al. A meta-analysis of the randomized controlled trials on elective neck dissection versus therapeutic neck dissection in oral cavity cancers with clinically node-negative neck [Review]. Eur J Cancer 2011; 47(5):320-324, 2011 May.:.
30. Ferris RL, Xi LQ, Seethala RR, Chan J, et al. Intraoperative qRT-PCR for Detection of Lymph Node Metastasis in Head and Neck Cancer. Clin Cancer Res 2011; 17:1858-1866.
31. Frydrych AM, Parsons R, Threlfall T, Austin N, et al. Oral cavity squamous cell carcinoma survival by biopsy type: a cancer registry study. Aust Dent J 2010; 55:378-384.
32. Granata R, Miceli R, Orlandi E, et al. Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study. Ann Oncol 2011. [Epub ahead of print] [09]
33. Hong AM, Dobbins TA, Lee CS, Jones D, et al. Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer 2010; 103:1510-1517.
34. Hong AM, Dobbins TA, Lee CS, Jones D, et al. Use of cyclin D1 in conjunction with human papillomavirus status to predict outcome in oropharyngeal cancer. Int J Cancer 2011; 128:1532-1545.
35. Huber GF, Fritzsche FR, Zullig L, Storz M, et al. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx. Int J Cancer 2011; 129:1404-1409.
36. Ihloff AS, Knecht R, Tribius S. HPV infection in head and neck squamous cell carcinoma (HNSCC) [German]. HNO 2010; 58:1163-1167.
37. Jarboe EA, Willis M, Bentz B, Buchmann L, et al. Detection of Human Papillomavirus Using Hybrid Capture 2 in Oral Brushings From Patients With Oropharyngeal Squamous Cell Carcinoma. Am J Clin Pathol 2011; 135:766-769.
38. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006; 24:5630-5636. [14] (Pubitemid 46631302)
39. Lundberg M, Leivo I, Saarilahti K, Makitie AA, et al. Increased incidence of oropharyngeal cancer and p16 expression. Acta Otolaryngol (Stockh) 2011; 131:1008-1011.
40. Mehanna H, Beech T, Nicholson T, et al. The prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer: a systematic review and meta-analysis of trends by time and region. Head Neck (in press). [06]
41. Näsman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009; 125:362-366. [04]
42. Oliveira LR, Oliveira-Costa JP, Araujo IM, Soave DF, et al. Cancer stem cell immunophenotypes in oral squamous cell carcinoma. J Oral Pathol Med 2011; 40:135-142.
43. Park IS, Chang XF, Loyo M, Wu GS, et al. Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers. Cancer Prev Res 2011; 4:207-217.
44. Park JW, Pitot HC, Strati K, Spardy N, et al. Deficiencies in the Fanconi Anemia DNA Damage Response Pathway Increase Sensitivity to HPV-Associated Head and Neck Cancer. Cancer Res 2010; 70:9959-9968.
45. Popovic B, Jekic B, Novakovic I, Lukovic L, et al. Cancer genes alterations and HPV infection in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2010; 39:909-915.
46. Posner MR, Lorch JH, Goloubeva O, Tan M, et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol 2011; 22:1071-1077.
47. Ramqvist T, Dalianis T. Oropharyngeal Cancer Epidemic and Human Papillomavirus. Emerg Infect Dis 2010; 16:1671-1677.
48. Ramqvist T, Dalianis T. Review AnEpidemic of Oropharyngeal Squamous Cell Carcinoma (OSCC) Due to Human Papillomavirus (HPV) Infection and Aspects of Treatment and Prevention [Review]. Anticancer Res 2011; 31: 1515-1519.
49. Snietura M, Piglowski W, Jaworska M, Mucha-Malecka A, et al. Impact of HPVinfection on the clinical outcome of p-CAIR trial in head and neck cancer. Eur Arch Otorhinolaryngol 2011; 268:721-726.
50. Terada A, Hasegawa Y, Yatabe Y, Hanai N, et al. Follow-up after intraoperative sentinel node biopsy of N0 neck oral cancer patients. Eur Arch Otorhinolaryngol 2011; 268:429-435.
51. Thavaraj S, Stokes A, Guerra E, et al. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice. J Clin Pathol 2011; 64:308-312. [18]
52. Tribius S, Ihloff AS, Rieckmann T, Petersen C, et al. Impact of HPV status on treatment of squamous cell cancer of the oropharynx: What we know and what we need to know [Review]. Cancer Lett 2011; 304:71-79.